
    
      The REVERSE PAS will estimate the 3-year survival probability of freedom from heart failure
      hospitalization and heart failure events in patients implanted with a Medtronic CRT-D device
      who meet the expanded indication criteria with a QRS duration â‰¤ 150 ms.
    
  